汇添富中证医药ETF联接C(007077)财务指标
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 本期已实现收益 |
-869,210.58 |
-8,759,887.01 |
-4,603,070.17 |
-8,808,249.11 |
| 本期利润 |
-8,138,803.29 |
9,782,240.12 |
3,823,453.60 |
-19,350,093.24 |
| 加权平均基金份额本期利润 |
-0.07 |
0.07 |
0.03 |
-0.12 |
| 本期加权平均净值利润率(%) |
-8.35 |
8.23 |
2.95 |
-14.31 |
| 本期基金份额净值增长率(%) |
-7.66 |
4.69 |
2.63 |
-12.10 |
| 期末可供分配利润 |
-18,916,026.60 |
-10,115,204.59 |
-16,404,934.27 |
-21,600,211.76 |
| 期末可供分配基金份额利润 |
-0.17 |
-0.10 |
-0.12 |
-0.14 |
| 期末基金资产净值 |
92,666,358.31 |
90,441,094.10 |
122,271,794.84 |
131,718,420.90 |
| 期末基金份额净值 |
0.83 |
0.90 |
0.88 |
0.86 |
| 基金份额累计净值增长率(%) |
-16.95 |
-10.06 |
-11.83 |
-14.09 |
微信公众号
证券之星APP
基本资料
